Taficita 200mg/25mg
Emtricitabine 200mg Tenofovir Alafenamide 25mg Tablet
Emtricitabine/Tenofovir Alafenamide 200mg/25mg treats HIV-1 in adults/adolescents and lowers HIV risk in high-risk men. FDA-approved & well-tolerated
- Strengths 200mg/25mg
- Form Tablet
- Packaging Size 30 TAB
- Packaging Type Box
- Manufacturer Mylan
Description of Taficita 200mg/25mg
Emtricitabine/Tenofovir Alafenamide 200mg/25mg is a prescription antiretroviral medication used to treat HIV-1 infection in adults and adolescents aged 12 years and older. It is also approved to reduce the risk of acquiring HIV in at-risk HIV-negative men who have sex with men. As a nucleoside reverse transcriptase inhibitor (NRTI), this combination helps suppress the virus and prevent its multiplication. It is usually used with other antiretroviral agents as part of a complete treatment regimen. Emtricitabine/Tenofovir Alafenamide offers a safer kidney and bone profile compared to other HIV treatments.
Ingredients of Taficita 200mg/25mg
- Emtricitabine – 200 mg
- Tenofovir Alafenamide – 25 mg
- Inactive excipients as per formulation
Usage of Taficita 200mg/25mg
- Take one tablet orally once daily.
- Can be taken with or without food.
- Always follow your doctor’s dosage instructions.
- Do not skip doses or stop without medical advice.
Precautions for Taficita 200mg/25mg
- Not for use in individuals allergic to any ingredients.
- Regular monitoring of liver and kidney function is recommended.
- Inform your doctor if pregnant, breastfeeding, or taking other medications.
- Use with caution in patients with hepatitis B co-infection.
- Must be used as part of a complete HIV treatment or prevention plan.
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
